Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2204660 | MHC (MHC) | infection | NA | NA | NA | unclassified | |
| during quiescent states without infection or rejection after transplantation, however, a rather restricted expression of class i and class ii donor mhc antigens is present. | |||||||
| 2204660 | HLA (HLA) | liver transplantation | NA | NA | NA | unclassified | |
| liver transplantation is performed successfully across major hla differences between donor and recipient. | |||||||
| 2204660 | NA (NA) | bacterial infections | NA | NA | NA | unclassified | |
| a strong induction of class i (hla-a,b,c; beta 2-microglobulin) and class ii (hla-dr,dq,dp) mhc antigens was demonstrated on hepatocytes, bile duct epithelium and endothelial cells during rejection episodes and viral and bacterial infections. | |||||||
| 2204660 | HLA-A (HLA-A) | bacterial infections | NA | NA | NA | unclassified | |
| a strong induction of class i (hla-a,b,c; beta 2-microglobulin) and class ii (hla-dr,dq,dp) mhc antigens was demonstrated on hepatocytes, bile duct epithelium and endothelial cells during rejection episodes and viral and bacterial infections. | |||||||
| 2204660 | DP (HAPLOTYPE) | bacterial infections | NA | NA | NA | unclassified | |
| a strong induction of class i (hla-a,b,c; beta 2-microglobulin) and class ii (hla-dr,dq,dp) mhc antigens was demonstrated on hepatocytes, bile duct epithelium and endothelial cells during rejection episodes and viral and bacterial infections. | |||||||
| 2204660 | HLA-DR (HLA-DR) | bacterial infections | NA | NA | NA | unclassified | |
| a strong induction of class i (hla-a,b,c; beta 2-microglobulin) and class ii (hla-dr,dq,dp) mhc antigens was demonstrated on hepatocytes, bile duct epithelium and endothelial cells during rejection episodes and viral and bacterial infections. | |||||||
| 2204660 | HLA (HLA) | liver transplants | NA | NA | NA | unclassified | |
| the role of hla matching in liver transplants in large clinical studies, with specific immunological testing however, remains to be investigated. | |||||||
| 2207341 | HLA (HLA) | transplantation | NA | cyclophosphamide | NA | unclassified | |
| marrow transplantation was performed from an hla genotypically identical sister after conditioning with cyclophosphamide. | |||||||
| 2211189 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| patients who have become split lymphoid chimeras (t cells of donor origin, b cells and monocytes of host origin) following transplantation of hla-haploidentical marrow for the treatment of severe combined immunodeficiency disease provide a unique model for the study of tolerance. | |||||||
| 2211189 | HLA (HLA) | severe combined immunodeficiency | NA | NA | NA | unclassified | |
| patients who have become split lymphoid chimeras (t cells of donor origin, b cells and monocytes of host origin) following transplantation of hla-haploidentical marrow for the treatment of severe combined immunodeficiency disease provide a unique model for the study of tolerance. | |||||||
Copyright 2024